CHIKUNGUNYA VIRUS
Clinical trials for CHIKUNGUNYA VIRUS explained in plain language.
Never miss a new study
Get alerted when new CHIKUNGUNYA VIRUS trials appear
Sign up with your email to follow new studies for CHIKUNGUNYA VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial launches for First-Ever chikungunya vaccine
⭐️ VACCINE ⭐️ Not yet recruitingThis is a large, late-stage study to test a new vaccine designed to prevent chikungunya, a painful mosquito-borne illness. It will enroll over 6,000 healthy adolescents and adults who have not had chikungunya before. The main goal is to see if the vaccine safely prevents people f…
Matched conditions: CHIKUNGUNYA VIRUS
Phase: PHASE3 • Sponsor: Bavarian Nordic • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:30 UTC
-
Scientists test nanoparticle vaccine against painful mosquito virus
⭐️ VACCINE ⭐️ Not yet recruitingThis is a first-in-human study to check the safety and immune response of a new experimental vaccine against chikungunya virus. The trial will enroll 40 healthy adults aged 18-60 who will receive two injections six weeks apart. Researchers will closely monitor participants for si…
Matched conditions: CHIKUNGUNYA VIRUS
Phase: EARLY_PHASE1 • Sponsor: Gylden Pharma Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 12, 2026 13:50 UTC